Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate the pituitary gland to release natural growth hormone in a pulsatile manner. It is one of the most researched peptides for reducing visceral fat and supporting body composition.

 

Benefits

•  Stimulates natural growth hormone release

•  Significantly reduces visceral (abdominal) fat

•  Improves body composition and lean mass

•  Supports fat metabolism and lipolysis

•  Enhances IGF-1 levels

•  Improves lipid profiles in research models

•  Supports better insulin sensitivity

•  Potential anti-aging effects through elevated GH

•  Improves recovery and tissue repair

•  Supports overall metabolic health

•  May improve sleep quality and energy levels

•  Helps reduce waist circumference in studies

 

Research Dosing Schedule

A common simple protocol used in laboratory studies is 1–2 mg of Tesamorelin administered subcutaneously once daily (typically in the morning or evening) on a continuous basis. At 2 mg per day, one 10 mg vial will last approximately 5 days.

 

Reconstitution Instructions

Each vial contains 10 mg of Tesamorelin in lyophilized (powder) form.

•  Add 2 mL of bacteriostatic water for injection to the vial.

•  Gently swirl (do not shake) until the powder is fully dissolved.

•  This creates a concentration of 5 mg per mL.

•  On a standard U-100 insulin syringe: 0.2 mL (20 units) = 1 mg of Tesamorelin.
Therefore, for the 2 mg dose: draw 0.4 mL (40 units on the syringe).

 

Storage

•  Unreconstituted vials: Store in a cool, dry place or refrigerator.

•  After reconstitution: Refrigerate the solution and use within 30 days. Do not freeze.

 

Packaging Note

Packaging may vary.

 

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is intended strictly for laboratory and scientific research purposes only.